肝癌治疗靶点及相关药物研究进展

Research progress in target and related drugs for hepatocellular carcinoma

肝癌是世界范围内最常见的恶性肿瘤之一,其发病率和死亡率正在逐年上升,严重威胁着人类的健康。尽管在临床上肝癌是以手术治疗为主,但是其术后五年复发率超70%。因此,采用靶向药物治疗也是肝癌治疗的一种重要手段。本文就近年来肝癌治疗的靶点与相关药物的研究进行综述,拟为肝癌的靶向治疗方法提供参考。

Hepatocellular carcinoma is a common malignant tumor. Its incidence and mortality are increasing year by year, and is a serious threat to human health. Although surgical treatment remains a major choice for hepatocellular carcinoma, the 5 year recurrence rate is over 70%. Therefore, targeted drug therapy very an important for hepatocellular carcinoma. This article reviews the targets and related drugs for hepatocellular carcinoma treatment in recent years, and expects to provide a reference for targeted therapy for hepatocellular carcinoma.